Auto-antibody to 7,12-dimethylbenz(a)anthracene-induced leukemic cells in rats as detected by immune adherence

Role of the Immune System in the Growth of an Isotransplanted Urethan-Induced Lymphosarcoma

Two groups of (SWR×C57BL)F1 mice were injected subcutaneously with two quantitatively different cell suspensions from a uretan-induced thymic lymphoma of the same hybrid combination. Each of these groups was divided before the neoplastic isograft into the following sub-groups: controls, cyclophosphamide injected, X-irradiated and BCG injected mice. Percentage of takes, tumor diameters and mortality provided the parameters for the evaluation of the tumor growth. With the higher inoculum of neoplastic cells (5×105) only cyclophosphamide was effective in enhancing the take percentage 10 days after the isograft. With the smaller inoculum (5 × 103) all treatments were effective on tumor growth although the inhibitory action of BCG was not as strong as the enhancing action of the immune depressive treatments. The results are interpreted as evidence of a specific antigenicity of urethan-induced lymphoma.